entertainment -WSS

entertainment

author：entertainment 2025-09-06 04:13:02 - browse：7

Mathai Mammen crosses his arms and looks into the camera — coverage from STAT — FogPharma CEO Mathai Mammen Boston Globe Photo Import

Oncology startup FogPharma just closed a $145 million Series E round, the company confirmed, reaching a late stage of financing that few other biotechs have hit in recent years.

FogPharma, which is headquartered in Cambridge, Mass., is developing cancer treatments using corkscrew-shaped peptides called helicons that could possibly better breach cells.

As CEO Mathai Mammen sees it, very few exemplary medicines shuttle off of drug companies’ pipelines, wade through clinical trials, and end up in the hands of physicians and patients in a given year. Far more often, pharma and biotech companies are pushing out drugs that are incrementally better than what came before, extending cancer patients’ survival by a few more months, halting their tumor growth for a little while longer. But FogPharma could deliver something truly unique, Mammen said.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： Gritstone Bio's cancer vaccine test, and more on Novartis' deal

WSS

United colonoscopy coverage change 'may cost lives,' doctors say

Readout LOUD: Venture capital, Gilead, and more M&A

Cancer drug shortages should be causing more outrage

Hollywood unions extend contract negotiations for actors

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Sports medicine is finally prioritizing gender equality

explore

entertainment

entertainment

Malaria cases in Florida and Texas: Here’s what you need to know

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Duchenne breakthrough therapy leaves behind pioneering families

Dobbs anniversary: the lost opportunity of abortion as health care

Medicare details structure of new drug price negotiation program

AI gets buy

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Guidelines to prevent youth baseball injuries need more muscle

Activists slam private health insurers over coverage restrictions

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

entertainment

A protest over insulin prices is seen as a fight for life

Dobbs anniversary: the lost opportunity of abortion as health care

In age of alternative facts, a scholarly course on calling out crap

Malaria cases in Florida and Texas: Here’s what you need to know

Drug repurposing or repositioning? The language matters

Affirmative action in medical school literally saved lives

knowledge

Wikipedia

knowledge

leisure time